Skip to main content
Log in

CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Long-chain fatty acids (LCFA) are the major energy substrate for heart and their oxidation is important for achieving maximal cardiac work. However, the mechanism of uptake of LCFA by myocardium has not been clarified. We previously reported that bovine myocardial LCFA transporter has a sequence homology to human CD36. Clinically, total defect of myocardial uptake of radiolabeled long-chain fatty acid analog [123I-BMIPP: Iodine-123 15-(p-iodophenyl)-(R,S)-methylpentadecanoic acid] has been reported in some restricted cases, but the etiology has not been clarified. In the present study, we analyzed CD36 expression and CD36 gene in subjects who showed total lack of myocardial 123I-BMIPP accumulation, and, vice versa, evaluated myocardial 123I-BMIPP uptake in subjects with CD36 deficiency. Four unrelated subjects were evaluated; Two were found to have negative myocardial LCFA accumulation by 123I-BMIPP scintigraphy, after which the expression of CD36 on their platelets and monocytes was analyzed. Remaining two subjects were identified as CD36 deficiency by screening, then 123I-BMIPP scintigraphy was performed. Expression of CD36 on platelets and monocytes was measured by flow cytometric analysis. The molecular defects responsible for CD36 deficiency was detected by allele-specific restriction enzyme analysis. CD36 expression was totally deficient in all 4 subjects on both platelets and monocytes. Two subjects were homozygous for a 478C→T mutation. One was heterozygous for the dinucleotide deletion of exon V and single nucleotide insertion of exon X, and remaining one was considered to be heterozygous for the dinucleotide deletion of exon V and an unknown gene abnormality. All cases demonstrated a completely negative accumulation of myocardial LCFA despite of normal myocardial perfusion, which was evaluated by thallium scintigraphy. In addition, all cases demonstrated apparently normal hepatic LCFA accumulation Thus, these findings suggested that CD36 acts as a major myocardial specific LCFA transporter in humans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abumrad NA, El-Maghrabi MR, Amri EZ, Lopez E, Grialdi PA: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665–17668, 1993

    Google Scholar 

  2. Tanaka T, Kawamura K: Isolation of myocardial membrane long-chain fatty acid-binding protein; homology with a rat membrane protein implicated in the binding or transport of long-chain fatty acids. J Mol Cell Cardiol 27: 1613–1622, 1995

    Google Scholar 

  3. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA: Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction and transfusion medicine. Blood 80: 1105–1115, 1992

    Google Scholar 

  4. Tandon NN, Kralisz NU, Jamieson GA: Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264: 7576–7583, 1989

    Google Scholar 

  5. Asch AS, Barnwell J, Silverstein RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest 79: 1054–1061, 1987

    Google Scholar 

  6. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811–11816, 1993

    Google Scholar 

  7. Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, Nakase T, Sekiguchi S: A new platelet-specific antigen, Naka involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 57: 213–217, 1989

    Google Scholar 

  8. Tomiyama Y, Take H, Ikeda H, Mitani T, Furubayashi T, Mizutani H, Yamamoto N, Tandon NN, Sekiguchi S, Jamieson GA, Kurata Y, Yonezawa T, Tarui S: Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV. Blood 75: 684–687, 1990.

    Google Scholar 

  9. Kashiwagi H, Honda S, Tomiyama Y, Mizutani H, Take H, Honda Y, Kosugi S, Kanayama Y, Kurata Y, Matsuzawa Y: A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV. Thromb Haemostas 69: 481–484, 1993

    Google Scholar 

  10. Kashiwagi H, Tomiyama Y, Kosugi S, Shiraga M, Lipsky RH, Kanayama Y, Kurata Y, Matsuzawa Y: Identification of molecular defects in a subject with type I CD36 deficiency. Blood 83: 3545–3552, 1994

    Google Scholar 

  11. Kashiwagi H, Tomiyama Y, Honda S, Kosugi S, Shiraga M, Nagao N, Sekiguchi S, Kanayama Y, Kurata Y, Matsuzawa Y: Molecular basis of CD36 deficiency; evidence that a 478C-T substitution (proline90–serine) in CD36 cDNA accounts for CD36 deficiency. J Clin Invest 95: 1040–1046, 1995

    Google Scholar 

  12. Kashiwagi H, Tomiyama Y, Nozaki S, Honda S, Kosugi S, Shiraga M, Nakagawa T, Nagao N, Kanakura Y, Kurata Y, Matstizawa Y: A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb Vasc Biol 16: 1026–1032, 1996

    Google Scholar 

  13. Take H, Kashiwagi H, Tomiyama Y, Honda S, Honda Y, Mizutani H, Furubayashi T, Karasuno T, Nishiura T, Kanayama Y, Kurata Y, Matsuzawa Y: Expression of GPIV and Nak' antigen on monocytes in Naka negative subjects whose platelets lack GPIV. Brit J Haematol 84: 387–391, 1993

    Google Scholar 

  14. Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K: Platelet glycoprotein IV (CD36) deficiency is associated with the absence (Type I) or the presence (Type II) of glycoprotein IV on monocytes. Blood 83: 392–397, 1994

    Google Scholar 

  15. Knapp Mr, Kropp J: Iodine-123–labeled fatty acids for myocardial single photonemission tomography: Current status and future perspectives. Eur J Nucl Med 22: 361–381, 1995

    Google Scholar 

  16. Knapp Mr, Franken P, Kropp J: Cardiac SPECT with iodine-123–labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 36: 1022–1030, 1995

    Google Scholar 

  17. Tateno M, Tamaki N, Yukihiro M, Kudoh T, Hattori N, Tadamura E, Nohara-R, Suzuki T, Endo K, Konishi J: Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 37: 1981–1985, 1996

    Google Scholar 

  18. Chen SL, Uehara T, Morozumi T, Yamagami H, Kusuoka H, Nishimura T: Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: Assessment by radial long-axis SPET. Nucl Med Commun 16: 336–343, 1995

    Google Scholar 

  19. Ohtsuki K, Sugihara H, Umamoto I, Nakamura T, Nakagawa T, Nakagawa M: Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15–(p-iodophenyl)-3–R, S-methylpentadecanoic acid (123I-BMIPP). Nucl Med Commun 15: 441–447, 1994

    Google Scholar 

  20. Hwang EHH, Yamashita A, Takemori H, et al.: Absent myocardial I-123 BMIPP uptake in a family. Ann Nucl Med 10: 445–448, 1996

    Google Scholar 

  21. Kudoh T, Tamaki N, Magata Y, Konishi J, Nohara R, Iwasaki A, Ono S, Ohtake Y, Sugihara H, Kuze K, Tsujimura Y, Miyazaki T: Metabolism substrate with negative myocardial uptake of iodine-123–BMIPP. J Nucl Med 38: 548–553, 1997

    Google Scholar 

  22. Tanaka T, Sohmiya K, Kawamura K: Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29: 121–127, 1997

    Google Scholar 

  23. Van der Vusse GJ, Glatz JFC, Starn HCG, Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72: 881–940, 1992

    Google Scholar 

  24. Rodrigues B, Cam MC, McNeffi JH: Myocardial substrate metabolism; implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169–179, 1995

    Google Scholar 

  25. DeGrella RF, Light RJ: Uptake and metabolism of fatty acids by dispersed adult rat heart myocytes. II. Inhibition by albumin and fatty acid homologues, and the effect of temperature and metabolic reagents. J Biol Chem 255: 9739–9745, 1980

    Google Scholar 

  26. Rose H, Hennecke T, Kammermeier H: Sarcolemmal fatty acid transfer in isolated cardiomyocytes governed by albumin/membrane-lipid partition. J Mol Cell Cardiol 22: 833–892, 1990

    Google Scholar 

  27. Harmon CM, Luce P, Beth AH, Abumrad NA: Labeling of adipocyte membranes by sulfo-N-succinimidyl derivates of long-chain fatty acids: Inhibition of fatty acid transporter. J Membrane Biol 121: 261–268, 1991

    Google Scholar 

  28. Stremmel W, Strohmeyer G, Borchard F, Kochwa S, Berk PD: Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci USA 82: 4–8, 1985

    Google Scholar 

  29. Stremmel W, Lotz G, Strohmeyer G, Berk PD: Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. J Clin Invest 75: 1068–1076, 1985

    Google Scholar 

  30. Stremmel W: Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport system. J Clin Invest 81: 844–853, 1988

    Google Scholar 

  31. Fujii S, Kawaguchi H, Yasuda H: Purification of high affinity fatty acid receptors in rat myocardial sarcolemmal membranes. Lipids 22: 544–546, 1987

    Google Scholar 

  32. Schaffer JE, Lodish HF: Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79: 427–436, 1994

    Google Scholar 

  33. Harmon CM, Aburnrad NA: Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and amino-terminal sequence of an 88–M protein implicated in transport of long-chain fatty acids. J Mem Biol 133: 43–49, 1993

    Google Scholar 

  34. Abumrad NA, Park JH, Park CR: Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J Biol Chem 259: 8945–8953, 1984

    Google Scholar 

  35. Kurata C, Kobayashi A, Yamazaki N: Dual tracer autoradiographic study with thallium-201 and radioiodinated fatty acid in cardiomyopathic hamsters. J Nucl Med 30: 80–87, 1989

    Google Scholar 

  36. Takeishi Y, Chiba J, Abe S, Tonooka I, Komatani A, Tomoike H: Heterogeneous myocardial distribution of iodine-123 15-(piodophenyl)-3–R, S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy. Eur J Nucl Med 19: 775–782, 1992

    Google Scholar 

  37. Kusaka Y, Tanaka T, Okamoto F, Terasaki F, Matsunaga Y, Miyazaki H, Kawamura K: Effect of sulfo-N-succinimidyl palmitate on the rat heart: Myocardial long-chain fatty acid uptake and cardiac hypertrophy. J Mol Cell Cardiol 27: 1605–1612, 1995

    Google Scholar 

  38. Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M, Koizumi T, Nikaido H, Hayakawa J, Kuwajima, M, Saheki T: Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 326: 267–271, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nozaki, S., Tanaka, T., Yamashita, S. et al. CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 192, 129–135 (1999). https://doi.org/10.1023/A:1006816702425

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006816702425

Navigation